Impax Laboratories (IPXL) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts IPXL Hot Sheet
Price: $18.30 --0%
Financial Fact:
Net income before noncontrolling interest: -179.34M
Today's EPS Names:
CGEH, NAKA, APOG, More
Financial Fact:
Net income before noncontrolling interest: -179.34M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Impax Laboratories (NASDAQ: IPXL) reported Q2 EPS of $0.18, $0.04 better than the analyst estimate of $0.14. Revenue for the quarter came in at $202.1 million versus the consensus estimate of $195.62 million.
GUIDANCE:
Impax Laboratories sees FY2017 EPS of $0.55-$0.70, versus the consensus of $0.66.
For earnings history and earnings-related data on Impax Laboratories (IPXL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- MakeMyTrip (MMYT) PT Raised to $84 at Goldman Sachs
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
